Docoh
Loading...

CLSN Celsion

Celsion Corp . is a clinical stage oncology drug company. It focuses on cancer treatments, including directed chemotherapies, DNA-mediated immunotherapy and RNA-based therapies. The firm engages in the research and development of pharmaceutical products for cancer treatments. Its portfolio includes deoxyribonucleic acid-mediated immunotherapy and ribonucleic acid-based therapies. It operates through the Celsion and ThermoDox brands. The company was founded by Yim-Pan Cheung in 1982 and is headquartered in Lawrenceville, NJ.

Company profile

Ticker
CLSN
Exchange
Website
CEO
Michael Tardugno
Employees
Incorporated
Location
Fiscal year end
Former names
CHEUNG LABORATORIES INC
SEC CIK
IRS number
521256615

CLSN stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

19 Mar 21
12 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from Celsion earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 17.16M 17.16M 17.16M 17.16M 17.16M 17.16M
Cash burn (monthly) 391.85K (positive/no burn) 1.6M 1.54M 1.24M 1.3M
Cash used (since last report) 1.34M n/a 5.46M 5.26M 4.25M 4.45M
Cash remaining 15.83M n/a 11.7M 11.9M 12.91M 12.72M
Runway (months of cash) 40.4 n/a 7.3 7.7 10.4 9.8

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
19 Mar 21 Chow Pok Yu Augustine Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock Grant Aquire A No No 2.24 40,000 89.6K 183,689
19 Mar 21 Hooper Robert W Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock Grant Aquire A No No 2.24 40,000 89.6K 179,737
19 Mar 21 Fritz Frederick J. Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock Grant Aquire A No No 2.24 40,000 89.6K 180,118
19 Mar 21 Braun Donald P Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock Grant Aquire A No No 2.24 40,000 89.6K 151,357
19 Mar 21 Voss Andreas Option to Purchase Celsion Corporation Common Stock Celsion Corporation Common Stock Grant Aquire A No No 2.24 40,000 89.6K 151,357

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 0 3 EXIT
Opened positions 0 0
Closed positions 3 0 NEW
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 0 108 EXIT
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change
Old Second National Bank Of Aurora 0 -50 EXIT
Arkadios Wealth Advisors 0 -43 EXIT
Emerald Advisers 0 -15 EXIT

Financial report summary

?
Competition
Codiak Biosciences
Management Discussion
  • Comparison of Fiscal Year Ended December 31, 2020 and Fiscal Year Ended December 31, 2019.
  • For the year ended December 31, 2020, our net loss was $21.5 million compared to a net loss of $16.9 million for the year ended December 31, 2019. The Company recognized $1.85 million and $1.82 million in tax benefits from the sale of its New Jersey net operating losses under the Technology Business Tax Certificate Program in each of the fourth quarters of 2020 and 2019, respectively. With $17.2 million in cash and cash equivalents, coupled with approximately $43 million of gross proceeds received from the sale of equity in the first quarter of 2021 and up to $1.85 million in expected proceeds from the sale of the State of New Jersey net operating losses it applied for in 2020, the Company believes it has sufficient capital resources to fund its operations through 2023.
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: Abbott, abundance, admitting, advisor, AKS, Alba, Allied, Altium, Alto, AMEDIX, amenable, Amersham, analyzing, Anthra, antibody, antigen, Arizona, assumption, Asta, AstraZeneca, attendance, attended, attending, Ayrton, bachelor, backdating, Basel, Bausch, Bayer, behavior, Behring, Biden, Bill, biographical, biology, Biomedical, Biomira, biopharma, bioterrorism, bladder, Boehringer, bold, Bonaventure, book, boost, boundary, Box, Brazil, breadth, Broadway, Brookline, brought, Brunswick, built, calendar, caption, captioned, career, carefully, Caribbean, carrier, cast, Cayman, Centocor, CEO, certified, certify, CFO, chain, Chicago, CIC, circumstance, clarification, claw, COBRA, Coleman, column, COMP, compatible, concept, conduit, confluence, constantly, constitutionality, constructively, contemplated, content, contest, CRADA, crossed, CSL, cum, CVI, cyclophosphamide, Cytogen, Dassault, dealer, delegate, delegated, delegation, demographic, denominated, deployment, detriment, diagnostic, dictating, Diego, disability, discharging, disregarding, dissolution, distancing, Dkt, doctoral, dollar, double, dozen, Dutch, earliest, easily, economy, eighteen, emphasizing, engineering, entry, eventual, eventually, evolutionary, exacerbate, excessive, excise, excitement, exciting, excusing, expressly, extinguishment, faith, fault, fellow, Fidler, FL, Floor, footnote, forensic, founder, Francisco, freedom, frozen, Fundacao, GeneMedicine, GenVec, George, Getulio, GmbH, GP, graduate, Grand, guideline, Hamburg, Harmony, Harvard, heading, hearing, helper, Hoffmann, House, household, Houston, humoral, immunology, Importantly, impressive, IMS, incumbent, inflammatory, insider, Insight, Inspector, intradermally, intramuscularly, intratumoral, invoiced, ITT, Japanese, Jessen, job, jointly, Joseph, judgement, justify, Kaisun, KGA, Khatri, Kobinger, laude, leadership, Legislature, lender, lent, liaison, lifetime, likelihood, Lincoln, linked, literacy, Lomb, London, LP, LPC, lump, Magnetic, Mannheim, marginally, Marine, Martin, Master, MBA, mBC, Medica, Medidata, Mercer, Merck, Meridian, merit, MFN, MFS, Microbiology, mimic, misleading, mitomycin, monotherapy, monovalent, motivate, mouse, MSc, multifunctional, multiplying, multitude, multivalent, mutation, mutational, Mylan, narrative, Nest, NeuroDx, neurosurgery, neutralizing, ninety, noncash, nonrenewal, Novavax, nuclear, nucleocapsid, NY, occasional, Ohio, opposed, opsonization, organizational, orientation, Outboard, outright, Overview, owner, pancreatic, PanDox, parallel, pathogen, Paulo, Paycheck, payroll, pecuniary, peer, pension, people, Pfizer, Pharma, philosophy, PLACCINE, plaintiff, pledging, Plough, podiatric, polymeric, postdoctoral, PPP, premedical, pro, promissory, promptly, propensity, properly, prophylactic, proportionate, prudent, purview, quantify, Radford, rata, ratification, reapplied, reappointed, reassessed, reconsideration, redoubling, regain, regained, Regression, relaying, renamed, renegotiate, repaid, repayment, reposition, resignation, Resonance, retention, retired, retirement, retroactive, revolutionize, Roche, rollout, routinely, running, Rush, Sandoz, Sao, Sarnoff, SBA, SCA, Schering, science, Segregated, sequence, Serono, Shortly, Silicon, simple, sliding, Society, Songbird, sound, sounding, spanning, Spar, SPC, Spike, spun, Squibb, staffing, staggered, stake, Sterling, stimulate, subcutaneously, successor, sum, summa, Super, surface, survey, tactical, Taiho, talent, talented, taxation, tenure, tool, Town, traditional, TSX, twelfth, twenty, Ugland, undergraduate, underway, unexercised, unprecedented, unregistered, unrestricted, untrue, unusual, unvested, uptake, upward, urge, urgent, USA, vacancy, vaccine, Valeo, Valley, vast, vigorously, vii, virtual, vote, voted, voting, VP, Waterhouse, web, welfare, Wesley, West, whatsoever, William, Winthrop, yearly, York, ZLB
Removed: Argentina, ATM, balanced, BCNU, brain, Bulgaria, CA, Cantor, CCNU, clearer, collected, conferring, confirming, Croatia, cumulated, Czech, Daegu, Denmark, deposited, dividend, dwell, enabling, escalating, Estonia, examined, exempt, Finland, Fitzgerald, formal, Gastroenterology, Greece, Hepatology, hoc, Hungary, incremental, Ireland, Israel, Korea, Kyungpook, largest, Latvia, launched, Lithuania, maker, Malta, matrix, mild, minimizing, modeling, OfferingSM, pegylation, perpetual, persuasive, Peru, Poland, Portugal, preferentially, presence, principle, progressive, prompted, radio, readout, registrational, Republic, Romania, Russia, simulation, Singapore, Slovakia, Slovenia, SM, split, sRFA, strongly, suffering, suggest, Sweden, Taiwan, Tak, unpredictable, unresectable, Vietnam, Won, write, Young, Zealand